Overdue Last read · last published · next check
Last read 3 days ago, longer than this feed's 10 hours schedule.
A major vaccine maker has warned that global warming is helping widen the spread of tick-borne encephalitis (TBE) and chikungunya, raising fresh concerns that diseases traditionally concentrated in specific regions could increasingly threaten populations in new parts of the world.
WASHINGTON: A routine blood test could be entering a new era after the U.
A personalized cancer vaccine from Moderna and Merck has delivered one of the most important clinical results yet for mRNA technology outside infectious diseases, reducing the risk of high-risk melanoma returning and spreading when added to Merck's immunotherapy Keytruda.
GREENBELT, Maryland: A former senior US health official who worked as an adviser to Dr.
Nicotine pouches are emerging as one of the tobacco industry's biggest bets for a future beyond cigarettes, with rapid sales growth, high margins and relatively lighter regulation helping products such as Zyn and Velo attract growing attention from investors and tobacco companies.
ISLAMABAD: Pakistan is moving closer to setting official prices for 52 newly registered lifesaving medicines, with Prime Minister Shehbaz Sharif expected to meet the federal health and finance ministers and senior Drug Regulatory Authority of Pakistan (DRAP) officials to discuss the matter, according to government sources.
CAIRO/GAZA: Cancer patients in Gaza are facing a worsening treatment crisis, with doctors reporting that cancer-related deaths are occurring at two to three times the pre-war rate as the territory's specialised cancer-care capacity has been severely damaged and thousands of patients remain unable to travel abroad for treatment.
WASHINGTON: A blood test designed to detect signals from multiple types of cancer in a single sample is moving toward a major US regulatory test, with the US Food and Drug Administration (FDA) set to convene an expert advisory panel next month to review GRAIL's Galleri multi-cancer early detection test.
WASHINGTON: The vaccine technology that became globally familiar during the COVID-19 pandemic has reached another major milestone: the US Food and Drug Administration (FDA) has approved MFLUSIVA, Moderna's mRNA-based vaccine against seasonal influenza, for people aged 50 years and older.
WASHINGTON: US President Donald Trump has signed an executive order targeting major changes to the country's childhood vaccination recommendations, including a narrower list of routinely recommended vaccines and greater spacing between childhood shots, despite warnings from paediatricians and public-health experts.
NEW YORK: Cholesterol management is entering a new phase as new lipid-lowering therapies and updated clinical guidelines are expanding the options for people who need to reduce low-density lipoprotein cholesterol (LDL-C), commonly known as "bad" cholesterol.
